Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is investigating potential legal claims arising from alleged false statements about FDA clearance requirements for one of the company's key products...
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is investigating potential legal claims arising from alleged false statements about FDA clearance requirements for one of the company's key products...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.